India, China Revoke Drug Patents for Western Manufacturers
In August 2013, India’s patent appeal board revoked patents on three drugs produced by Western firms, including Allergan’s glaucoma treatment Ganfort and GlaxoSmithKline’s breast cancer drug Tykerb. The drugs failed to meet the board’s “improved efficacy” test, which is being used with... Read More